FDA approves bladder cancer diagnostics

The US Food & Drug Administration has given approval to Israel’s Applied Spectral Imaging for its in-vitro aid that can detect chromosomal aberrations in bladder cancer. The SpotScan GenASIs Scan & Analysis system targets cells based on colour, size and their signals pattern.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000720938&fid=1725

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.